Previous work has identified NF1 gene deletions in multiple neuroblastoma cell lines [29], likely contributing to the lack of NF1 protein seen in these cell lines and suggesting that neuroblastoma tumors with reduced or absent NF1 expression are likely to be sensitive to MEK inhibition. Here, MAP2K7 is linked to neuroblastoma.